ID: ALA5219324

Max Phase: Preclinical

Molecular Formula: C18H18N4

Molecular Weight: 290.37

Associated Items:

Representations

Canonical SMILES:  CC/N=C/c1ccc2ccc3ccc(/C=N/CC)nc3c2n1

Standard InChI:  InChI=1S/C18H18N4/c1-3-19-11-15-9-7-13-5-6-14-8-10-16(12-20-4-2)22-18(14)17(13)21-15/h5-12H,3-4H2,1-2H3/b19-11+,20-12+

Standard InChI Key:  COVBORTXYUMAOV-AYKLPDECSA-N

Associated Targets(Human)

quadruplex DNA 2700 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.37Molecular Weight (Monoisotopic): 290.1531AlogP: 3.66#Rotatable Bonds: 4
Polar Surface Area: 50.50Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.10CX LogP: 4.25CX LogD: 4.25
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.54Np Likeness Score: -0.37

References

1. Figueiredo J, Carreira-Barral I, Quesada R, Mergny JL, Cruz C..  (2022)  Synthesis and evaluation of 2,9-disubstituted-1,10-phenanthroline derivatives as G-quadruplex binders.,  73  [PMID:36208542] [10.1016/j.bmc.2022.116971]

Source